COMPARATIVE EFFECTIVENESS OF AGGRESSIVE VS NON-AGGRESSIVE TREATMENT FOR HIGH-GRADE PROSTATE CANCER ACROSS DIFFERENT COMORBIDITY LEVELS

被引：0
|
作者：
Daskivich, Timothy
Lai, Julie
Dick, Andrew
Setodji, Claude
Hanley, Janet
Litwin, Mark
Saigal, Christopher
机构：
来源：
JOURNAL OF UROLOGY | 2015年 / 193卷 / 04期
关键词：
D O I：
10.1016/j.juro.2015.02.361
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP9-01
引用
收藏
页码：E102 / E102
页数：1
相关论文
共 50 条
  • [21] A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease
    Al Olama, Ali Amin
    Kote-Jarai, Zsofia
    Schumacher, Fredrick R.
    Wiklund, Fredrik
    Berndt, Sonja I.
    Benlloch, Sara
    Giles, Graham G.
    Severi, Gianluca
    Neal, David E.
    Hamdy, Freddie C.
    Donovan, Jenny L.
    Hunter, David J.
    Henderson, Brian E.
    Thun, Michael J.
    Gaziano, Michael
    Giovannucci, Edward L.
    Siddiq, Afshan
    Travis, Ruth C.
    Cox, David G.
    Canzian, Federico
    Riboli, Elio
    Key, Timothy J.
    Andriole, Gerald
    Albanes, Demetrius
    Hayes, Richard B.
    Schleutker, Johanna
    Auvinen, Anssi
    Tammela, Teuvo L. J.
    Weischer, Maren
    Stanford, Janet L.
    Ostrander, Elaine A.
    Cybulski, Cezary
    Lubinski, Jan
    Thibodeau, Stephen N.
    Schaid, Daniel J.
    Sorensen, Karina D.
    Batra, Jyotsna
    Clements, Judith A.
    Chambers, Suzanne
    Aitken, Joanne
    Gardiner, Robert A.
    Maier, Christiane
    Vogel, Walther
    Doerk, Thilo
    Brenner, Hermann
    Habuchi, Tomonori
    Ingles, Sue
    John, Esther M.
    Dickinson, Joanne L.
    Cannon-Albright, Lisa
    [J]. HUMAN MOLECULAR GENETICS, 2013, 22 (02) : 408 - 415
  • [22] Evaluation of the MiCheck MIA test performance in differentiating aggressive from non-aggressive prostate cancer: The MiCheck-01 prospective trial.
    Shore, Neal D.
    Pieczonka, Christopher Michael
    Henderson, Ralph Jonathan
    Bailen, James L.
    Beebe-Dimmer, Jennifer Lynn
    Ruterbusch, Julie J.
    Saltzstein, Daniel R.
    Concepcion, Raoul S.
    Borotkanics, Robert
    Levin, Rachel
    Wissmueller, Sandra
    Campbell, Douglas
    Walsh, Brad
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [23] FAILURE TO CURE SECONDARY HIGH-GRADE NON-HODGKIN LYMPHOMA BY AGGRESSIVE POLYCHEMOTHERAPY
    OVERKAMP, F
    MEUSERS, P
    ENGELHARD, M
    BRITTINGER, G
    [J]. BLUT, 1986, 53 (03): : 222 - 222
  • [24] DNA repair gene panel mutations in young onset and aggressive vs non aggressive prostate cancer cases in the UK
    Eeles, R.
    Saunders, E.
    Wakerell, S.
    Whitmore, I.
    Cieza-Borrella, C.
    Govindasami, K.
    Dadaev, T.
    Kote-Jarai, Z.
    Leongamornlert, D.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [25] Validation of Stem Cell markers in Clinical Prostate Cancer: α6-Integrin is Predictive for Non-Aggressive Disease
    Hoogland, A. Marije
    Verhoef, Esther I.
    Roobol, Monique J.
    Schroder, Fritz H.
    Wildhagen, Mark F.
    van der Kwast, Theo H.
    Jenster, Guido
    van Leenders, Geert J. L. H.
    [J]. PROSTATE, 2014, 74 (05): : 488 - 496
  • [26] Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels
    Walsh, Thomas J.
    Shores, Molly M.
    Krakauer, Chloe A.
    Forsberg, Christopher W.
    Fox, Alexandra E.
    Moore, Kathryn P.
    Korpak, Anna
    Heckbert, Susan R.
    Zeliadt, Steven B.
    Kinsey, Chloe E.
    Thompson, Mary Lou
    Smith, Nicholas L.
    Matsumoto, Alvin M.
    [J]. PLOS ONE, 2018, 13 (06):
  • [27] PRL-3 increases the aggressive phenotype of prostate cancer cells in vitro and its expression correlates with high-grade prostate tumors in patients
    Edwards, Donna R.
    Moroz, Krzysztof
    Zhang, Haitao
    Mulholland, David
    Abdel-Mageed, Asim B.
    Mondal, Debasis
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (02) : 402 - 412
  • [28] Characterizing a discernible stromal fibroblastic gene signature in the shift from high-grade prostatic intraepithelial neoplasia to aggressive prostate cancer
    Alexanderani, Mohammad K.
    Queiroz, Lucio
    Omar, Mohamed
    Zanettini, Claudio
    Pakula, Hubert
    Marchionni, Luigi
    Loda, Massimo
    [J]. CANCER RESEARCH, 2023, 84 (06)
  • [29] High-grade prostate cancer is associated with low serum testosterone levels
    Schatzl, G
    Madersbacher, S
    Thurridl, T
    Waldmüller, J
    Kramer, G
    Haitel, A
    Marberger, M
    [J]. PROSTATE, 2001, 47 (01): : 52 - 58
  • [30] TREATMENT RESULTS WITH AN AGGRESSIVE CHEMOTHERAPEUTIC REGIMEN (MACOP-B) FOR INTERMEDIATE-GRADE AND SOME HIGH-GRADE NON-HODGKINS LYMPHOMAS
    SCHNEIDER, AM
    STRAUS, DJ
    SCHLUGER, AE
    LOWENTHAL, DA
    KOZINER, B
    LEE, BJ
    WONG, G
    CLARKSON, BD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (01) : 94 - 102
12345